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Phosphoinositides (PIPs) play key roles in signaling
and disease. Using high-resolution quantitative
mass spectrometry, we identified PIP-interacting
proteins and profiled their binding specificities
toward all seven PIP variants. This analysis revealed
405 PIP-binding proteins, which is greater than the
total number of phospho- or ubiquitin-binding do-
mains. Translocation and inhibitor assays of identi-
fied PIP-binding proteins confirmed that ourmethod-
ology targets direct interactors. The PIP interactome
encompasses proteins from diverse cellular com-
partments, prominently including the nucleus. Our
data set revealed a consensus motif for PI(3,4,5)P3-
interacting pleckstrin homology (PH) domains, which
enabled in silico identification of phosphoinositide
interactors. Members of the dedicator of cytokinesis
family C exhibited specificity toward both PI(3,4,5)P3
and PI(4,5)P2. Structurally, this dual specificity is
explained by a decreased number of positively
charged residues in the L1 subdomain compared
with DOCK1. The presented PIP-binding proteome
and its specificity toward individual PIPs should be
a valuable resource for the community.INTRODUCTION
Phosphatidylinositol is a negatively charged phospholipid that
represents less than 5% of the total phospholipid pool at the
cytosolic side of eukaryotic cell membranes (Nasuhoglu et al.,
2002). Phosphatidylinositol can be phosphorylated by a variety
of kinases on position 3, 4, or 5 of the inositol ring in seven
different combinations. Phosphorylated forms of phosphatidyl-
inositols, known as phosphoinositides (PIPs), play important
roles in lipid-mediated cell signaling, membrane trafficking,578 Cell Reports 6, 578–591, February 13, 2014 ª2014 The Authorsand diseases involving these processes (Di Paolo andDeCamilli,
2006). PIPs can act as precursors for secondary messengers or
interact directly with proteins to orchestrate spatiotemporal
activation of downstream signaling components (Berridge and
Irvine, 1984; Cantley, 2002).
Despite biological interest in the PIP signaling pathways, our
knowledge about the proteins that specifically interact with PIPs
is limited. This is mainly due to the absence of ‘‘unbiased’’ tech-
nologies for detecting PIP interactions on a proteome-wide
scale. Affinity matrices carrying tethered PIP variants have
been used to isolate PIP-interacting proteins (Painter et al.,
2001; Krugmann et al., 2002). Although this constituted an
elegant biochemical approach, only a few PIPs could be in-
vestigated at a given time, and the specificity of the identified
PIP-interacting candidates was unclear. Mass spectrometry
(MS)-based proteomics has emerged as a key technology for
comprehensive mapping of proteomes (de Godoy et al., 2008;
Altelaar et al., 2013) and posttranslational modifications
(PTMs) (Jensen, 2006; Witze et al., 2007), and is frequently
employed to identify proteins bound to a ‘‘bait’’ such as pep-
tides, RNA, or DNA. A central challenge in these experiments
is to distinguish proteins that bind nonspecifically to the bait
(background binders) from genuine interactors (specific
binders). For example, previous studies performed pull-down
experiments with immobilized PIPs to determine PI(3,5)P2,
PI(4,5)P2, and PI(3,4,5)P3 interactors (Pasquali et al., 2007;
Catimel et al., 2008, 2009; Rowland et al., 2011). Using low-res-
olution ion traps for data acquisition, these reports identified
some of the known PIP binders, but also many additional
proteins that are unlikely to be specific PIP binders. One can
address this challenge by performing interaction screens in a
quantitative format, most accurately by using stable isotope
labeling approaches such as stable isotope labeling by amino
acids in cell culture (SILAC) (Ong and Mann, 2005; Bantscheff
et al., 2007). A strategy employing double-encoded quantitation
for PIP studies was recently demonstrated, but the analysis was
limited to a specific cellular compartment and only protein inter-
actors for a single PIP were probed (Dixon et al., 2011; Lewis
et al., 2011).
Figure 1. Experimental Setup
(A) Triple-encoded SILAC cell lysates were individually incubated with various PIPs.
(B) Three biological replicate experiments were performed to assess reliability and reproducibility. Each experiment contained four triple-encoded SILAC
experiments (a total of 12 samples, labeled A1–C4).
(C) Each triple-encoded SILAC sample yielded quantitative information that was used to establish the PIP specificity for each identified protein. Data for two
peptides from sample B1 (PLCD3 and PDPK1 peptide) and one PDPK1 peptide derived from sample C4 are depicted. Combining the quantitative information
from all three experiments yielded a relative PIP specificity ratio (PSR) that corresponds to the PIP specificity for each quantified protein.Here, we used triple-encoded SILAC quantification and high-
resolution MS to systematically profile protein interaction speci-
ficities for all seven PIP variants. The data reveal an extensive
catalog of PIP interactors and a quantitative estimate of their
preferences for different PIP isoforms. We identified a large
number of specific PIP interactors and validated several candi-
dates by membrane translocation assays, which we discuss
further below with regard to known PIP-binding domains (Seet
et al., 2006). By probing highly specific PIP interactors in our
data set, we established an extended PI(3,4,5)P3 consensus
motif, allowing for in silico identification of PI(3,4,5)P3-binding
proteins. Moreover, our data reveal insights into known PIP-
binding protein families, as demonstrated by the identification
of PIP-binding proteins, and extend the known PIP-binding
specificity of dedicator of cytokinesis (DOCK) family members.
Collectively, the presented data set provides a valuable resource
for identifying PIP-binding proteins in human cells.CRESULTS
PIP Interaction Profiling Strategy
To identify PIP-interacting proteins and quantitatively profile the
binding specificities for the different PIP isoforms, we used a
SILAC-based proteomics approach (Figure 1A). HeLaS3 cells
were grown under identical conditions in media containing
‘‘light,’’ ‘‘medium,’’ or ‘‘heavy’’ isotope-labeled variants of lysine
and arginine (Ong et al., 2002). For an unbiased investigation of
the human PIP interactome, all PIP isoforms were individually
immobilized on agarose beads (PIP beads; Echelon) and incu-
bated separately with light-, medium-, or heavy-labeled SILAC
cell lysates. In the triple-SILAC approach, the interaction profile
of three conditions can be analyzed simultaneously in a single
experiment. However, to distinguish ‘‘background binders’’
from PIP-specific interactors, light-labeled SILAC lysates were
incubated with beads coupled to PI(0), whereas phosphorylatedell Reports 6, 578–591, February 13, 2014 ª2014 The Authors 579
PIPs were incubated with either medium or heavy SILAC-labeled
lysates. As a result, four SILAC experiments were needed to
address the entire PIP interactome comprehensively (Figure 1B).
The bound proteins were subsequently eluted, separated by
SDS-PAGE, digested into peptides, and analyzed by liquid chro-
matography coupled to high-resolution tandemMS (LCMS/MS).
The protein-specific PIP affinity was determined by a quantita-
tive comparison of peptide abundances across experiments as
each peptide occurred as a SILAC triplet (Figure 1C). If the rela-
tive peptide abundance between light and medium or heavy
SILAC peaks was 1:1, the identified protein was considered a
background binder. In contrast, proteins that were significantly
enriched in heavy-isotope-encoded samples appeared with
high SILAC ratios and hence were considered as PIP-specific
interactors. An example of the triple-SILAC intensity profile is
illustrated in Figure 1C for the peptide sequence NLDLAAP
TAEEAQR belonging to the protein PLCD3. No affinity toward
PI(0) is observed in the light SILAC state (marked by a black ar-
row), whereas an abundant peak in the medium SILAC state sig-
nifies a strong PI(4,5)P2 interaction. For the heavy SILAC state, a
peak ofmedium abundance demonstrates a relatively weaker af-
finity toward PI(3,4,5)P3. These data not only confirm the well-
known affinity of PLCD3 for PI(4,5)P2 (Pawelczyk and Matecki,
1999) but also reveal the protein’s affinity for PI(3,4,5)P3,
showing that PLCD3 exhibits dual PIP specificity. In comparison,
the light and medium SILAC abundances for the peptide
sequence LGCEEMEGYGPLK belonging to PDPK1 demonstrate
that the protein has no specificity for PI(0) or PI(4,5)P2 (Figure 1C,
middle section). Instead, an abundant signal present only in the
heavy SILAC state demonstrates a strong affinity for PI(3,4,5)P3.
Likewise, another peptide sequence LGCEEMEGYGPLK from
PDPK1 protein confirms the strong affinity for PI(3,4,5)P3,
whereas no affinity is observed for PI(4)P and PI(0) (Figure 1C,
right panel). Combined, these data confirm the well-known PIP
specificity of PDPK1 (Alessi et al., 1997; Stephens et al., 1998;
Table S1) and provide a positive control for our screen. More-
over, since protein quantification was performed on the peptide
level, every acquired mass spectrum of the identified peptides
contributed to quantitative information for assessment of PIP
affinity. In all experiments, we required that PIP interactors
must be identified and quantified by a minimum of two unique
peptides. Since many peptides from PIP interactors were quan-
tified several times during their chromatographic elution time,
the described PIP interactions were based on extensive quanti-
tative data with high statistical significance.
Identifying the PIP Interactome
To obtain a high-quality PIP interactome and also assess the
reproducibility of the approach, we analyzed three independent
biological replicates for PIP interactors (Figure 1B). In total, our
experiments identified 3,551 proteins representing a collection
of potential PIP-interacting proteins (Table S2). Statistical anal-
ysis of the data set shows that the results from these unfiltered
replicate experiments were highly consistent. For example, a
comparison of the PI(3,4,5)P3 affinity data derived from sample
A1 with the corresponding data from samples A4, B1, and C4
(Figure 1B, labeled Exp.A, Exp.B, and Exp.C) yielded a Pearson
correlation above 0.70 between all three individual experiments.580 Cell Reports 6, 578–591, February 13, 2014 ª2014 The AuthorsIt is worth noting that in interaction experiments, the actual
SILAC ratios do not have to be identical between experiments,
as they primarily serve to segregate background from specific
interactors. Still, the correlation coefficients demonstrate that
high quantitative reproducibility was achieved between the
analyzed replicates (Figure 2A).
Having established that our data set contains highly reproduc-
ible protein ratios, we next determined specific PIP interactors
by a ‘‘significant-outlier strategy,’’ as only a small subset of the
3,551 identified proteins are expected to be true PIP-interacting
proteins. Each identified protein yielded a total of three SILAC
ratios corresponding to light/medium, light/heavy, and medium/
heavy from each SILAC sample analyzed (Figure 1B). These
ratios were all extracted and normalized according to the
summed peptide intensity of each protein relative to the signal
for PI(0) (Figure 2B). Since high reproducibility was achieved in
our analyses (Figure 2A), all PIP affinity ratios derived from the
same protein across different samples were combined and
normalized using the common control PI(0) (e.g., the PI(3,4,5)
P3 affinity data derived from sample A1 were combined with
the same PIP ratios from samples A4, B1, and C4). This allowed
us to merge results from all experiments and to determine seven
PIP specificity ratios (PSRs) for all identified proteins (one PSR
for each investigated PIP isoform).
For statistical filtering, all PSR values were initially analyzed by
boxplot analysis (Figure 2C), and only significant outliers (p <
0.01) were further considered. Then, the SD for each PSR value
was calculated and only proteins that exhibited a PSR > 2 SDs
were finally classified as PIP-interacting proteins. These filtered
and significant PIP-interacting proteins are represented in Fig-
ure 2A by green (p < 0.01) and red (p < 0.001) dots. In this way,
we identified a total of 405 proteins, constituting the largest
experimentally determined PIP interactome reported to date
(Tables S1 and S2). Among these PIP-binding proteins, we
identified several well-characterized PIP-interacting proteins,
including GAB1 (Rodrigues et al., 2000), RASA2 (Cozier et al.,
2003), RASA3 (Cozier et al., 2003), PHLDB1 (Zhou et al., 2010),
CYTH3 (Klarlund et al., 1997), and PREX1 (Welch et al., 2002).
Our data set confirms the known specificity of these proteins
as visualized by their ‘‘PIP affinity and specificity chart’’ (Fig-
ure S1). This chart is based upon the derived PSR values for
each protein (see above) and depicts the relative affinity and
overall specificity of each PIP interactor toward all PIP isoforms.
Each bar refers to a protein’s affinity toward a specific PIP, with a
taller bar representing a relatively higher affinity. In addition to
well-characterized interactors, several PIP-interacting proteins
identified in our proteomics screen were recently validated by
other groups through standard biochemical approaches (Feeser
et al., 2010; Komaba and Coluccio, 2010; Krick et al., 2012).
For further validation of our identified PIP-binding proteome,
we performed membrane-translocation studies for several
proteins upon platelet-derived growth factor (PDGF) stimulation
in serum-starved SUM159 cells. Activation of the phosphatidyl-
inositol 3-kinase (PI3K) pathway by PDGF causes a rapid buildup
of PI(3,4,5)P3 at the plasma membrane (PM), and many PIP3
interactors have been reported to translocate to the PM in
PDGF-stimulated cells, where they bind to PI(3,4,5)P3 (Auger
et al., 1989; Hawkins et al., 1992). Such PDGF-dependent
Figure 2. Data Correlation and Filtering
(A) Ratio plots from identified proteins with PI(3,4,5)P3 specificity, comparing proteins detected in sample A1 with the same proteins detected in samples A4, B1,
and C4. Green and red dots represent the identified PIP-interacting proteins after data filtering (green dots represent outliers with p < 0.01, and red dots represent
outliers with p < 0.001).
(B) Sorted ratio distribution of all ratios detected in sample A1.
(C) Boxplot of all PSR values calculated from all three experiments. Only proteins with a significantly enriched ratio (p < 0.01) were labeled as PIP interactors.translocation is demonstrated in Figure 3A for the well-char-
acterized PI(3,4,5)P3-binding protein AKT1. In addition, we per-
formed translocation assays for several PIP-interacting proteins,
including ESYT1, PHLDA2, CCDC120, and TBC1D2 (Figures
3B–3E). ESYTs belong to a family of evolutionarily conserved
mammalian proteins (referred to as extended synaptotagmin-
like proteins) that are known to contain C2 domains (Min et al.,
2007), and our analysis identified both ESYT1 and ESYT2 as
PIP-binding proteins (Table S1). Since ESYT2 was recently
demonstrated to be localized to the PM in a PI(4,5)P2-dependent
manner (Giordano et al., 2013), we decided to investigate the PM
translocation of ESYT1. To this end, we transfected SUM159
cells with full-length FLAG-tagged ESYT1, and after 5 min of
PDGF stimulation, we observed membrane translocation (Fig-
ure 3B), which did not occur in unstimulated cells. Similar trans-
location assays on additional PIP-binding proteins also revealed
clear PM translocation for PHLDA2, CCDC120, and TBC1D2,
thereby confirming their affinity for PI(3,4,5)P3 (Figures 3 and S2).
To validate the specificity of our findings, we performed a PI3K
inhibitor-dependent translocation study. SUM159 cells trans-Cfected separately with the PIP3-binding proteins TBC1D2 and
PHLDA2, along with the positive control AKT1, were stimulated
with PDGF in the presence or absence of the PI3K inhibitors
Wortmannin or LYS294002 (Figure 3F). The data confirmed the
PIP3-dependent translocation of the three targets upon PDGF
stimulation, and a residual translocation of TBC1D2 could be
observed upon PI3K inhibition. Since other PIPs besides PIP3
are known to accumulate at the PM upon PDGF stimulation
(Auger et al., 1989; Hawkins et al., 1992), these results suggest
that TBC1D2 (but not PHLDA2 or AKT1) would bind to these
PIPs. This is in agreement with our proteomics data, which report
that TBC1D2 exhibits dual specificity for both PI(4,5)P2 and
PI(3,4,5)P3, whereas PHLDA2 exclusively binds PI(3,4,5)P3
(Table S1). Accordingly, these results demonstrate that the pro-
teomics data can be utilized to decipher PIP specificities that are
not easily entangled by common biochemical approaches.
Additionally, we performed western blot analysis for several
full-length glutathione S-transferase (GST)-purified PIP-inter-
acting proteins (not preferentially binding to PIP3) after pulldown
with each of the seven PIP isoforms conjugated to agaroseell Reports 6, 578–591, February 13, 2014 ª2014 The Authors 581
Figure 3. Translocation Assays for Trans-
fected Full-Length PIP-Binding Proteins
(A) Positive control experiment for FLAG-AKT1 in
SUM159 cells upon 5 min of PDGF stimulation.
Clear PM translocation validates the known PIP-
binding affinities of AKT1 (green). Costaining with
pAKT1-antibody (red) serves as a control for PDGF
stimulation.
(B) FLAG-tagged ESYT1 translocates to the PM
upon PDGF stimulation, confirming the in vivo PIP-
binding affinity for ESYT1.
(C) GFP-PHLDA2.
(D) FLAG-CCDC120.
(E) FLAG-TBC1D2.
(F) Translocation to PM of full-length FLAG-tagged
AKT1, TBC1D2, and PHLDA2 is observed,
whereas translocation is abrogated upon pre-
treatment of cells with the PI3K inhibitors Wort-
mannin and LY294002. TBC1D2 experiences
residual PM translocation under PI3K inhibition
due to its dual specificity for both PI(4,5)P2 and
PI(3,4,5)P3.beads (Figure 4A). These results confirm the known and
observed specificity of DAB2 toward both PI(4,5)P2 and
PI(3,4,5)P3, and corroborate various PIP affinities reported in
our SILAC screen for BANF1, SNX24, and ACAP2 (Table S1).
As our proteomics approach allows for concurrent determina-
tion of PIP specificity and affinity toward all seven PIPs within the
same experiment, our data set reveals that PIP-binding proteins
often exhibit selectivity toward more than one PIP. Such PIP-
binding stereospecificity has been demonstrated for several
PIP-binding proteins, such as PHLDB1 (Zhou et al., 2010) and
DAB1 (Howell et al., 1999), highlighting that PIP-interacting pro-582 Cell Reports 6, 578–591, February 13, 2014 ª2014 The Authorsteins indeed exhibit stereospecificity
in vivo and that these proteins are likely
to encompass biological function. Our
proteomic analysis confirms the known
stereospecificity for PHLDB1 and DAB1,
and together with in vivo evaluation
of several PIP-interacting proteins, we
conclude that our data set contains
physiologically relevant PIP-binding
proteins. Although many known PIP-
interacting proteins were identified and
validated, we did not find all known PIP
interactors in our screen. As an example,
DOCK2 and DAPP1 were not identified
in our data set because these proteins
have very cell-type-specific expression
patterns (Dowler et al., 1999; Nishihara
et al., 1999). Unfortunately, such cell-
specific PIP-interacting proteins would
require analyses of a large number of
various cellular systems and conse-
quently are not identifiable in our current
setup.
To evaluate whether the identified
proteins were direct PIP interactors, weassessed all PIP-interacting proteins for physical and/or func-
tional interactions using the STRING software tool, which sepa-
rately reports known and predicted protein interactors based
upon direct and indirect associations (Snel et al., 2000). Although
STRING extracts experimental data from databases such as
BIND, DIP, GRID, HPRD, IntAct, MINT, and PID, as well as
curated data from Biocarta, BioCyc, Gene Ontology (GO),
KEGG, and Reactome, it does not encompass all direct or sec-
ondary PIP interactors. Still, STRING contains information on
thousands of protein interactions, including the most prominent
and well-studied PIP interactors. Secondary interaction partners
Figure 4. Properties of PIP-Binding Proteins
(A) Pulldown of the recombinant, GST-tagged, full-length proteins DAB2, BANF1, SNX24, and ACAP2with each of the seven PIP isoforms and PtdIns as a control
bound to agarose beads. PIP-binding was detected by immunoblot using a GST-specific antibody.
(B) Domain architecture of PIP-interacting proteins, indicating Pfam domains that are significantly overrepresented.
(C) Cellular distribution of PIP-interacting proteins. Proteins were assigned based on exclusive GO annotations.
(D) Distribution of identified proteins according to their PIP specificity. Dark-brown bars represent the total pool of PIP-binding proteins, and light-brown bars
represent nuclear annotated proteins only. A significant enrichment for PI(4)P-interacting proteins in the nucleus is observed.
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of these well-characterized PIP proteins are extensively
described in the literature and therefore are present in the data-
base. Importantly, STRING does not need to be comprehensive
to assess the presence of secondary binding proteins in our data
set. This secondary PIP interaction analysis, based upon exper-
imental prediction methods and high-confidence STRING
interactors (confidence score > 0.9 [von Mering et al., 2005]), re-
vealed that the vastmajority of proteins identified in our PIP inter-
actome are likely to be direct PIP interactors, since only a few
functional interactions are recorded in STRING among the PIP-
interacting proteins (Figure S3). Pfam domain analysis revealed
that PIP-interacting domains, such as the pleckstrin homology
(PH) (Haslam et al., 1993), calponin homology (CH) (Fukami
et al., 1996), RNA recognition motif (RBD) (Okada and Ye,
2009), and DOCK homology region (DHR) (Coˆte´ et al., 2005)
domains, were highly enriched among our identified PIP-inter-
acting proteins (Figure 4B). Taken together, these data confirm
that our approach permits a stringent and high-confidence iden-
tification of the PIP interaction proteome (Table S1).
Next, we assessed the cellular distribution of identified PIP-
interacting proteins and compared their distribution against the
entire human proteome (Figure 4C). Surprisingly, a significant
enrichment (p < 7.0 3 107) of nuclear PIP interactors was
evident, constituting the largest portion of identified PIP-inter-
acting proteins. In contrast, the number of cytosolic interactors
was significantly decreased (p < 5.5 3 103), demonstrating
that PIPs occupy several functionally distinct subcellular com-
partments. Our data are consistent with emerging evidence
that PIPs play important biological roles in the nucleus (Barlow
et al., 2010). To investigate whether interactors of any specific
PIP might be enriched within the nucleus, we compared the
distribution of the entire PIP interactome with its nuclear constit-
uents (Figure 4D). PI(4)P interactors were significantly (p < 4.03
103) enriched in the nucleus. These results are consistent with
previous reports of PI(4)P in nuclear matrix preparations (Payr-
astre et al., 1992), along with observations that membrane-free
nuclei retain the capability to produce significant amounts of
PI(4)P (Boronenkov et al., 1998). Moreover, the clear preference
for singly phosphorylated PI(4)P, and less binding to multiphos-
phorylated PIPs (with increased negative charge) demonstrate
that our data set entails specific PIP interactors and is not biased
toward electrostatic interactions.
TAPP1 and TAPP2 Exhibit Dual PIP Specificity
To assess the sensitivity and dynamic range of the developed
approach, we explored the PIP-binding properties of the
cytoplasmic adaptor proteins tandem-PH-domain-containing-
protein 1 (TAPP1) and TAPP2. These proteins assemble
signaling complexes at the PM, and TAPP1 was previouslyFigure 5. Establishing an In Silico Motif for PI(3,4,5)P3-Binding Protein
(A) Specificity chart for TAPP1 and TAPP2. Preferential binding is observed for P
(B) 3D structure of the PH1 domain derived from TAPP1. The PH1 domain structu
charged residues, conserved throughout PH domains with PI(3,4,5)P3 specificity
(C) Sequence alignment of identified PH domains with PI(3,4,5)P3 specificity, and
in red and hydrophobic residues are in blue. The sequence alignment allows for
(D) PM translocation assay for transfected full-length GFP-ADRBK1 in SUM159 ce
properties of ADRBK1. Costaining with pAKT1 antibody (red) serves as a contro
Cdemonstrated to bind strongly to PI(3,4)P2 through its PH2
domain (Hogan et al., 2004).
It has been demonstrated that besides having affinity for
PI(3,4)P2, the PH2 domain of TAPP1 (referred to as AA054961
in this study) can bind the headgroup of Ins(1,3,4,5)P4, which
shares structural similarity to PI(3,4,5)P3 (Ferguson et al.,
2000). Moreover, PM translocation was reported for the PH2
domain of TAPP2 upon PDGF stimulation of membrane-bound
receptors, whereas the PH1 domain did not translocate under
the same conditions (Supplemental Experimental Procedures;
Park et al., 2008). These results demonstrate that the PH2
domain of TAPP1 exhibits affinity for PI(3,4,5)P3 along with its
affinity for PI(3,4)P2. A recent study on the membrane penetra-
tion of various PH domains by quantitative surface plasmon
resonance established that the PH2 domain of TAPP1 binds
PI(3,4)P2 roughly 20 times more strongly than it binds PI(3,4,5)
P3 (Manna et al., 2007). Such distinct preferences are often diffi-
cult to determine through standard biochemical approaches,
which demonstrate the limited dynamic range of standard pro-
tein-lipid experiments (Dowler et al., 2000). In contrast, our
data confirm that both TAPP1 and TAPP2 exhibit dual affinity
toward PI(3,4)P2 and PI(3,4,5)P3 (Figure 5A) in agreement with
previous observations, validating the ability of our proteomics
approach to detect even subtle and distinct PIP-binding
properties.
The observed dual PIP-binding specificity is due to the prop-
erties of the PH2 domains of TAPP1 and TAPP2 as described
above. This is further highlighted by previous results demon-
strating that the PH1 domains of TAPP1 and TAPP2 are only
able to bind PI(3,4,5)P3 upon site-directed mutagenesis
(Thomas et al., 2001). To further investigate the PI(3,4,5)P3-bind-
ing properties of the PH2 domain of TAPP1 and TAPP2, we
superimposed its 3D structure onto known PI(3,4,5)P3-specific
PH domains (DAPP1, PDPK1, and AKT1). In this way, we identi-
fied three positively charged residues that are highly conserved
(Figure 5B, residues highlighted in blue). These positively
charged residues are in close proximity to the negatively
charged phospho-groups of PI(3,4,5)P3 and are important for
stabilizing the PIP interaction through their positive charges.
These observations are in full agreement with the fact that PH
domains are electronically polarized and exhibit strong positive
electrostatic potential in the proximity of the PIP-binding site (Ku-
tateladze, 2010).
A sequence alignment analysis of all PH domains identified in
our data set that exhibited PI(3,4,5)P3 specificity revealed a
strong conservation of these positively charged residues, which
highlights the importance of these residues for affinity toward
PI(3,4,5)P3 (Figure 5C, residues highlighted in red and marked
with an asterisk). In contrast, the PH1 domains of TAPP1 ands
I(3,4)P2 and PI(3,4,5)P3.
re is overlaid with PH domains from DAPP1 and FAPP1. Three highly positively
, are highlighted in blue.
PH1 and PH2 domains from TAPP1 and TAPP2. Charged residues are colored
extraction of an extended PI(3,4,5)P3-binding motif.
lls upon 5min of PDGF stimulation, confirming the in silico-derived PIP-binding
l for PDGF stimulation.
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TAPP2 do not show a similar conservation of positively charged
residues (Figure 5C, marked by arrows). Instead, they contain
several negatively charged amino acids (aspartic and glutamic
acids) at these positions. These negatively charged residues
are expected to have a counter-interacting effect on PIP inter-
action, which explains why the PH1 domain is only able to bind
PI(3,4,5)P3 after site-directed mutagenesis. In conclusion, our
data support previous observations that the PH2 domain of
TAPP1 and TAPP2 exhibit subtle affinity toward PI(3,4,5)P3
due to a conserved sequence in the PH2 domain harboring posi-
tively charged residues, a signature that is also found in other
known PI(3,4,5)P3-interacting PH domains.
Identification of an Extended PI(3,4,5)P3-Interacting PH
Domain Motif
Besides the conserved positively charged residues across
PI(3,4,5)P3 specific PH domains, the sequence alignment re-
vealed the presence of a highly conserved PI(3,4,5)P3 interaction
motif. The motif contains several determining residues and
stretches across the entire PH domain from a conserved glycine
at position 4 to a tryptophan at the C terminus of the PH domain
(Figure 5C). This motif is more extensive then the previously
reported PPBMmotif (putative PI(3,4,5)P3-binding motif [Isakoff
et al., 1998]) and the signature motif (Lietzke et al., 2000), which
both are confined to the N-terminal part of PH domains. An
in silico search identified 38 proteins harboring this PI(3,4,5)P3-
binding motif in the human genome (Table 1). For 36 out of the
38 proteins, the extended sequence motif falls within a known
PH domain, validating the specificity of the derived motif. Only
18 of the identified candidates have previously been reported
as PIP interactors.
Among interactors, the in silico analysis revealed that all of
the PLEKHA family proteins, except for PLEKHA3 (FAPP1) and
PLEKHA8 (FAPP2), harbor a PH domain with specificity toward
PI(3,4,5)P3. Recent studies confirmed that the PH domains of
FAPP1 and FAPP2 exhibit affinity for PI(4)P, which further vali-
dates the PI(3,4,5)P3 specificity of our extended PH motif
(Godi et al., 2004). Notably, PLEKHA proteins often contain
more than one PIP-binding domain, and therefore may exhibit
stereospecificity toward several PIPs besides PI(3,4,5)P3, as
demonstrated by TAPP1 and TAPP2. However, our analysis re-
veals that the majority of PLEKHA proteins contain at least one
domain that is responsible for interaction with PI(3,4,5)P3.
Among the 38 candidates identified in silico, 15 were identified
in our MS screen. Two possible explanations for the fact that not
all 38 candidates were identified are that (1) some of these pro-
teins are likely to be expressed in a cell-type-specific manner
and therefore may not be present in the HeLa cells used in this
screen, and (2) some of these proteins are expressed at low
levels. For example, a published HeLa proteome (Olsen et al.,
2010) comprising 6,695 proteins identified only eight of the 38
candidates derived from the in silico analysis; however, all eight
proteins were identified in our MS screen.
Overall, the in silico analysis identified PI(3,4,5)P3-binding
PH domains from a wide range of proteins, including signaling
adaptor proteins, regulators of small GTPases, kinases, and
phosphatases. One PI(3,4,5)P3-binding protein identified
through the in silico analysis was ADRBK1, a kinase that586 Cell Reports 6, 578–591, February 13, 2014 ª2014 The Authorsspecifically phosphorylates the agonist-occupied form of the
beta-adrenergic receptor (Aziziyeh et al., 2009). ADRBK1 was
previously suggested to bind PI(4,5,)P2 (Touhara et al., 1995),
but was never predicted by other PIP motif analyses or demon-
strated to exhibit PI(3,4,5)P3-binding properties. To validate the
predicted affinity, we performed a membrane-translocation
assay as previously described. When transfected SUM159 cells
were stimulated with PDGF, a noticeable PM translocation of
GFP-tagged ADRBK1 was observed, confirming the in silico-
derived PIP-binding properties of ADRBK1 (Figures 5D and
S2). Since ADRBK1 is coupled to G protein-mediated signaling,
efficient translocation might require both PI3K and other G
protein subunits in a manner similar to that previously reported
for the PM translocation of PREX1 (Barber et al., 2007). Such
preferences are not easily discernible in the presented trans-
location setup; however, our results demonstrate the specificity
of the presented PI(3,4,5)P3-binding motif for in silico discovery
of PI(3,4,5)P3-binding proteins.
Our analysis predicts that about 12% of all annotated PH
domains in SwissProt (38 PH domains out of a total of 326)
have PI(3,4,5)P3 affinity. Moreover, our data suggest that PH
domainsmay exhibit PIP stereospecificity, which is in agreement
with observations from our PIP-interaction analysis and recent
studies in which PH domains showed varying specificity for
inositol pentakisphosphate (Lloyd et al., 2009). Together, these
data confirm our initial observation that PIP-interacting proteins
are widely present in cellular compartments and biological func-
tions, and suggest that PI(3,4,5)P3 plays an evenmore extensive
role in cellular signaling than was previously anticipated. Finally,
the described analysis demonstrates that in silico approaches
can complement experimental methods in identifying and vali-
dating PIP-interacting proteins and their specificity.
Analysis of DOCK Family Proteins as PIP Interactors
Our proteomics screen identified several members of the DOCK
protein family as PIP-interacting proteins. The DOCK family
consists of related proteins involved in intracellular signaling
networks, where they act as guanine nucleotide exchange
factors (GEFs) for small G proteins of the Rho family, such as
Rac and/or Cdc42. The DOCK family proteins consist of 11
proteins that are categorized into four subfamilies (DOCK-A,
DOCK-B, DOCK-C, and DOCK-D) based upon their sequence
homology (Figure 6A; Coˆte´ and Vuori, 2002). Among the 11
DOCK proteins, only DOCK1, DOCK4, and DOCK5 have previ-
ously been experimentally validated as PIP-interacting proteins
(Coˆte´ et al., 2005), and our proteomic analysis confirms the re-
ported affinity of these three DOCK proteins toward PI(3,4,5)P3
(Table S1). Moreover, our PIP analysis reveals that all DOCK
protein families act as PIP interactors, and that DOCK6,
DOCK7, and DOCK8 preferentially bind to PI(4,5)P2 and to a
lesser extent to PI(3,4,5)P3 (Figure 6B).
The interaction of DOCK1, DOCK4, and DOCK5 proteins with
PI(3,4,5)P3 is known to occur through the DHR-1 domain, which
is conserved throughout all DOCK proteins. The 3D structure of
the DOCK1 DHR-1 domain was recently determined, and it was
discovered that the PI(3,4,5)P3 interaction with DOCK1 occurs
through the L1 subdomain of DHR-1. Within this L1 subdomain,
three positively charged lysine residues were identified as being
Table 1. List of 38 Human Proteins Containing a PI(3,4,5)P3-Specific Binding Motif
Gene Name Protein Name Known PH Domain AA Region Known PI(3,4,5)P3 Interactor
ACAP1 Arf-GAP with coiled-coil, ANK repeat, and
PH-domain-containing protein 1
yes 270–351 yes
ACAP2 Arf-GAP with coiled-coil, ANK repeat, and
PH-domain-containing protein 2
yes 271–352 yes
ACAP3 Arf-GAP with coiled-coil, ANK repeat, and
PH-domain-containing protein 3
yes 273–354 yes
ADAP1 Arf-GAP with dual PH-domain-containing protein 1 yes 134–221 yes
ADAP2 Arf-GAP with dual PH-domain-containing protein 2 yes 137–224 yes
AKT1 RAC-alpha serine/threonine-protein kinase yes 10–99 yes
AKT2 RAC-beta serine/threonine-protein kinase yes 10–99 yes
AKT3 RAC-gamma serine/threonine-protein kinase yes 10–98 yes
ADRBK1 b-adrenergic receptor kinase 1 yes 563–643 no
ADRBK2 b-adrenergic receptor kinase 2 yes 563–643 no
DAPP1 dual adaptor for phosphotyrosine and
3-phosphotyrosine and 3-PIP
yes 169–256 yes
DEF6 differentially expressed in FDCP 6 homolog yes 221–303 yes
DGKH diacylglycerol kinase eta yes 70–149 no
DGKK diacylglycerol kinase kappa yes 221–303 no
EPHA3 ephrin type-A receptor 3 yes 367–457 no
GAB1 GRB2-associated-binding protein 1 yes 10–107 yes
GAB2 GRB2-associated-binding protein 2 yes 11–108 yes
GAB3 GRB2-associated-binding protein 3 yes 10–108 yes
GAB4 GRB2-associated-binding protein 4 yes 44–143 yes
SBF1 myotubularin-related protein 5 yes 1,766–1,856 yes
SBF2 myotubularin-related protein 13 yes 1,748–1,838 no
MYO10 myosin-X yes 1,217–1,301 yes
OSBPL9 oxysterol-binding protein-related protein 9 yes 7–90 no
PHLDB1 PH-like domain family B member 1 yes 1,261–1,361 yes
PHLDB2 PH-like domain family B member 2 yes 1,148–1,237 yes
PLEKHA1 PH-domain-containing family A member 1 yes 196–280 no
PLEKHA2 PH-domain-containing family A member 2 yes 203–289 no
PLEKHA4 PH-domain-containing family A member 4 yes 59–144 no
PLEKHA5 PH-domain-containing family A member 5 yes 174–259 no
PLEKHA6 PH-domain-containing family A member 6 yes 64–149 no
PLEKHA7 PH-domain-containing family A member 7 yes 169–273 no
PLEKHH1 PH-domain-containing family H member 1 yes 583–663 no
RASA2 Ras GTPase-activating protein 2 yes 609–724 yes
RASA3 Ras GTPase-activating protein 3 yes 581–696 yes
ARHGAP22 Rho GTPase-activating protein 22 yes 36–145 no
SWAP70 switch-associated protein 70 yes 215–297 yes
TAF1 transcription initiation factor TFIID subunit 1 yes 793–862 no
The predicted location of the motif falls within a known PH domain for 36 of the candidates.responsible for the PIP specificity of DOCK1 (Premkumar et al.,
2010). Sequence alignment of DHR-1 domains from all DOCK
family members reveals that these lysine residues are highly
conserved across DOCK proteins except for the DOCK-C family
members (DOCK6, DOCK7, and DOCK8), which contain only
two charged lysine residues in their L1 subdomain (Figure 6C).
Considering our previous observations regarding conservationCof charged residues in PH domains, and the known importance
of positive electrostatic interaction in PIP-binding domains
(Kutateladze, 2010), we suggest that the PIP specificity of
DOCK-C family members stems from the reduced number of
charged residues in their L1 domains. Since DOCK6, DOCK7,
and DOCK8 have only two charged lysine residues within their
L1 domain, this would allow for strong interaction with eitherell Reports 6, 578–591, February 13, 2014 ª2014 The Authors 587
(legend on next page)
588 Cell Reports 6, 578–591, February 13, 2014 ª2014 The Authors
PI(3,4)P2, PI(3,5)P2, or PI(4,5)P2, while still allowing some affin-
ity for PI(3,4,5)P3 to be retained. In contrast, three charged
lysine residues would create a very strong affinity for PI(3,4,5)
P3, with no other PIP being able to dock in the L1 domain as
previously described (Premkumar et al., 2010). Interestingly,
this dual PIP specificity of DOCK-C family proteins follows the
known dual GEF specificity of DOCK6, DOCK7, and DOCK8.
Generally, DOCK proteins act as GEFs for either Rac or
Cdc42; however, the DOCK-C family acts as a dual GEF for
both GTPases (Miyamoto and Yamauchi, 2010). Considering
that PIPs recruit Rho family GTPases to the PM via their
GEFs, the dual PIP specificity of DOCK6, DOCK7, and
DOCK8 would be an efficient way to regulate individual activa-
tion of Rac1 and Cdc42, and in turn activation of their down-
stream effectors (Bishop and Hall, 2000).
DISCUSSION
We have carried out a proteomic analysis of the human PIP inter-
actome using quantitative MS. The combination of high-resolu-
tion MS with triple-encoded SILAC allowed for reliable protein
identification and concurrent distinction between true PIP inter-
actors and background binding proteins. Triplicate analysis of
our PIP interaction screen revealed high reproducibility between
experiments.
Our approach efficiently assesses PIP interactions on a
global scale and reveals additional information about PIP-inter-
acting proteins. In previous studies, many PIP interactions were
established through in vitro assays, in which binding is often
analyzed using only a particular region and/or domain under
investigation rather than the full-length protein. Additionally, in-
teractions have often been characterized using strategies in
which all seven PIPs are concurrently introduced to a protein
of interest. Thus, subtle PIP specificities may be masked if
the affinity of a protein for any single PIP is particularly strong.
Furthermore, these approaches lack global data that can help
to disentangle interactions that occur through secondary pro-
teins. These limitations are greatly circumvented or alleviated
by individually introducing PIPs to whole-cell lysates in a
SILAC-based strategy.
Our approach provides an extended view of the PIP inter-
actome and identified a total of 405 PIP-interacting proteins,
including many well-known interactors as well as additional
interactors. Data analysis revealed that the PIP interactome
encompasses proteins from diverse cellular compartments,
prominently including the nucleus. A large proportion of them
have PIP-recognizing domains. The presence of such a domain
is a powerful mechanism to increase the local concentration of
the protein as warranted by cellular conditions, without going
through relatively slow gene-expression changes. This may
explain the unexpectedly large size of the PIP interactome.
Among some of the PIP-recognizing domains, the DHR-1Figure 6. The Entire DOCK Family Entails PIP-Binding Proteins
(A) Schematic structure of DOCK proteins and their division into subfamilies bas
(B) Sequence alignment of the DHR-1 domain from all 11 DOCK proteins. Green b
Highlighted in red are the charged residues within the L1 domain that are respon
(C) Specificity chart for various DOCK proteins. The individual specificities follow
Cdomain of the DOCK family was revealed to exhibit dual speci-
ficity according to the number of lysine residues residing within
its L1 subdomain. A higher affinity toward PI(3,4,5)P3 was
observed for DHR-1 domains harboring three lysine residues in
L1, whereas dual specificity toward PI(4,5)P2 and PI(3,4,5)P3
occurred when it contained only two lysines. This dual specificity
follows the DOCK-C family’s dual GEF activity for Rac1 and
Cdc42.
In conclusion, our data reveal that the PIP interactome is
remarkably expanded, such that it contains more protein inter-
actors than the total number containing either phospho- or ubi-
quitin-binding domains in the genome (Venter et al., 2001). We
anticipate that this data set will be a valuable resource for the
community, and may provide novel insights into the PIP inter-
actome and allow functional testing of proteins that were previ-
ously not known to be PIP interactors.
EXPERIMENTAL PROCEDURES
A detailed summary of all materials and methods used in this study can be
found in the accompanying the Supplemental Experimental Procedures.
Enrichment of PIP Protein Interactors
PIP beadswere obtained from Echelon Biosciences. One PIP variant was incu-
bated with one SILAC lysate state for 3 hr at 4C. Beads were washed five
times with washing buffer (10 mM HEPES pH 7.4, 150 mM NaCl, 0.25% Ige-
pal). Bound protein interactors were eluted by boiling PIP beads in Laemmli
Sample Buffer at 95C for 5 min. Proteins were resolved on 4%–20% SDS-
PAGE and stained with colloidal Coomassie blue, cut into 20 slices, and pro-
cessed for MS analysis.
MS Analysis
All MS experiments were performed on a nanoscale high-performance liquid
chromatography system connected to a hybrid linear trap quadrupole (LTQ)
Orbitrap mass spectrometer. TheMS instrument was operated in data-depen-
dent mode to automatically switch between full-scan MS and MS/MS acquisi-
tion. Survey full-scan MS spectra were acquired in the Orbitrap analyzer with
resolution R = 60,000. The ten most intense peptide ions with charge statesR
2 were sequentially isolated and fragmented by collision-induced dissociation
(CID) in the LTQ mass spectrometer.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2013.12.038.
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